Several lines of evidence indicate that in the human, insulin like gro
wth factor-I (IGF-I) is nutritionally regulated. Both energy and prote
in availability are required for maintenance of IGF-I. Measurements of
serum IGF I constitute a sensitive means for monitoring the response
of acutely ill patients to nutritional intervention. Serum IGF-I may a
lso serve as a marker for evaluation of nutritional status. Our findin
gs and those of others in animal models suggest that nutrients influen
ce synthesis and action of IGF-I and its binding proteins (IGFBPs) at
multiple levels. In fasting, liver growth hormone (GH) binding is decr
eased, providing one explanation for decreased IGF-I. In protein restr
iction, GH receptors are maintained, but there is evidence for a postr
eceptor defects. The latter results from pretranslational and translat
ional defects. Amino acid availability to the hepatocytes is essential
for IGF-I gene expression. Protein malnutrition not only decreases IG
F-I production rate, but also enhances its serum clearance and degrada
tion. Finally, there is evidence for selective organ resistance to the
growth-promoting effects of IGF-I in protein restricted rats. Copyrig
ht (C) 1995 by W.B. Saunders Company.